Apollo Endosurgery Inc.

NASDAQ: APEN · Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Apr 03, 2023, 10:00 PM

Apollo Endosurgery Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
21.31M 19.57M 19.31M 16.66M 16.17M 16.35M 16.61M 13.86M
Cost of Revenue
9.96M 8.84M 8.35M 7.29M 7.07M 7.12M 7.49M 6.35M
Gross Profit
11.36M 10.74M 10.96M 9.37M 9.1M 9.23M 9.12M 7.51M
Operating Income
-7.71M -6.29M -6.58M -7.25M -6.18M -4.5M -5.24M -3.75M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-9.38M -11.27M -10.38M -8.23M -10.47M -6.57M -2.95M -4.54M
Net Income
-9.55M -11.45M -10.43M -8.41M -10.4M -6.66M -3.02M -4.6M
Selling & General & Admin
15.2M 13.78M 14.17M 13.45M 11.86M 10.7M 11.34M 8.86M
Research & Development
3.48M 2.8M 2.92M 2.71M 2.48M 2.57M 2.55M 1.93M
Other Expenses
392K 450K 452K 456K 463K 467K 471K 474K
Operating Expenses
19.06M 17.03M 17.54M 16.62M 14.8M 13.73M 14.36M 11.26M
Interest Expense
1.09M 1.16M 1.21M 1.22M 4.29M 1.34M 1.33M 1.35M
Selling & Marketing Expenses
10.08M 8.58M 9.13M 8.22M 7.39M 6.12M 6M 4.79M
Cost & Expenses
29.02M 25.86M 25.89M 23.91M 21.87M 20.86M 21.85M 17.61M
Income Tax Expense
176K 172K 49K 187K -64K 90K 71K 59K
Shares Outstanding (Basic)
30.24M 40.85M 40.36M 39.65M 38.26M 29.02M 27.27M 26.31M
Shares Outstanding (Diluted)
30.24M 40.85M 40.36M 39.65M 38.26M 29.02M 27.27M 26.31M
EPS (Basic)
-0.32 -0.28 -0.26 -0.21 -0.27 -0.23 -0.11 -0.17
EPS (Diluted)
-0.32 -0.28 -0.26 -0.21 -0.27 -0.23 -0.11 -0.17
EBITDA
-4.36M -9.35M -8.43M -6.26M -8.66M -4.5M -5.24M -3.75M
EBIT
-4.69M -10.12M -9.17M -7M -6.18M -5.22M -1.61M -3.19M
Depreciation & Amortization
136K -3.06M -1.86M 983K 748K 752K 828K 904K